CoChat

Syndromic Panel-Based Testing in Clinical Microbiology

Open access

The DOI matches its Crossref record; 95 of the 96 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

SUMMARY: The recent development of commercial panel-based molecular diagnostics for the rapid detection of pathogens in positive blood culture bottles, respiratory specimens, stool, and cerebrospinal fluid has resulted in a paradigm shift in clinical microbiology and clinical practice. This review focuses on U.S. Food and Drug Administration (FDA)-approved/cleared multiplex molecular panels with more than five targets designed to assist in the diagnosis of bloodstream, respiratory tract, gastrointestinal, or central nervous system infections. While these panel-based assays have the clear advantages of a rapid turnaround time and the detection of a large number of microorganisms and promise to improve health care, they present certain challenges, including cost and the definition of ideal test utilization strategies (i.e., optimal ordering) and test interpretation.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/cmr.00024-17

Cites

95 of 96 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 96 references

Research works printed but not linked: 3

  1. White House. 2015. National action plan for combating antibiotic-resistant bacteria. White House, Washington, DC.
  2. Ramanan P, Gebrehiwot SA, Rucinski SL, Dylla BL, Wengenack NL, Hughes JG, Ihde SM, Patel R. 2016. Discrepancies between microbial detection and identification using the blood culture identification (BCID) FilmArray panel assay and standard subculture of positive blood culture bottles, abstr 57653, poster 188. Abstr IDWeek 2016, New Orleans, LA, 26 to 30 October 2016. http://www.idweek.org/.
  3. Gebrehiwot SA, Rucinski SL, Schwab JJ, Patel R, Snippes P. 2016. “Reflexive culture”—a strategy for laboratories adopting molecular testing for enteric pathogens, poster 188. Abstr ASM Microbe 2016, Boston, MA.

Cited by

See all 362

Metadata

Authors
Ramanan, P., Bryson, A. L., Binnicker, M. J., Pritt, B. S., & Patel, R.
Affiliations
Mayo Clinic (US)
Venue
Clinical Microbiology Reviews
Published
2018-01
Volume
31
Issue
1
ISSN
  • 0893-8512 (ISSN-L)
  • 1098-6618
OpenAlex
W2768305199
Cited by
308
References
93
Citations by year
2026: 31 · 2025: 33 · 2024: 37 · 2023: 36 · 2022: 36 · 2021: 38 · 2020: 38 · 2019: 38 · 2018: 19
FWCI
3.40
Type
journal article
Language
en
Open access
Licence
journals.asm.org/non-commercial-tdm-license (tdm)
Locations
  • Clinical Microbiology Reviews (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
  • Physical Sciences › Engineering › Biomedical Engineering › Biosensors and Analytical Detection
  • Health Sciences › Health Professions › Medical Laboratory Technology › Clinical Laboratory Practices and Quality Control
Keywords
multiplex PCR, pathogen detection, blood culture, respiratory infections, gastrointestinal infections, central nervous system infection, bloodstream infection, test interpretation
MeSH terms
Humans, Infections, United States, United States Food and Drug Administration, Molecular Diagnostic Techniques

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Syndromic Panel-Based Testing in Clinical Microbiology. https://app.cochat.ai/papers/10.1128/cmr.00024-17
The paper
Ramanan, P., Bryson, A. L., Binnicker, M. J., Pritt, B. S., & Patel, R. (2018). Syndromic Panel-Based Testing in Clinical Microbiology. Clinical Microbiology Reviews. https://doi.org/10.1128/cmr.00024-17

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.